DrugInfoSys

Sucralfate

Drug #681

Sucralfate is aluminium-sucrose complex, is a sulphated disaccharide developed for the treatment of peptic ulcer. It protects layer on gastro-duodenal mucosa by forming a complex with pepsin which adhere to active ulcers.

Primary Characteristics

It is of Synthetic origin and belongs to Glucofructose.

It is classified in Ulcer Healing pharmacological group. It is also classified under Antacids .

Non-proprietary name: Sucralfate.

Molecular structure of Sucralfate

Pharmacokinetics

None recorded.

Advertisement

Indications

Contraindications

None recorded.

Dosage

Sucralfate's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
1 g1 gEvery 6hPO
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
0 – 0Safety not established

Drug Interactions

Unknown18 interactions
5 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Sucralfate is known to cause more or less tolerable side effects which are usually transient. These include Constipation .

Warnings / Precautions

Do not take antacids 30min before and after sucralfate. Avoid use in patients with renal impairment. It should be used in pregnancy if clearly needed.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Multi-Ingredient Combinations

Tabs

Storage Conditions

Sucralfate should be stored Susp. Tab.

Drug Classification

  1. 1.17.1.2Anti-peptic ulcerants

Manufacturers